Key result
Machine learning outperforms traditional scores for predicting primary graft dysfunction after heart transplant with AUROCs up to ~0.87.
Why the study?
Primary graft dysfunction is a poorly predictable, life-threatening complication affecting 8-10% of heart transplant recipients and decreasing 1-year survival from 95% to 75%. Converging machine learning, multi-omics biomarker discovery, and advanced organ preservation technologies offer an opportunity to make it computable and potentially preventable.
Does an AI-enhanced framework integrating machine learning, multi-omics biomarkers, and advanced organ preservation improve the prediction and prevention of primary graft dysfunction in heart transplant recipients compared to traditional clinical risk scores and threshold-based assessments?
Does an AI-enhanced framework integrating machine learning, multi-omics biomarkers, and advanced organ preservation improve the prediction and prevention of primary graft dysfunction in heart transplant recipients compared to traditional clinical risk scores and threshold-based assessments?
This focused narrative review proposes a conceptual four-phase AI-enhanced pipeline integrating machine learning, multi-omics biomarkers, and machine perfusion analytics to transition primary graft dysfunction after heart transplantation from a poorly predictable complication into a computable and potentially preventable outcome.
Answers are grounded in this paper and cite their sources.
May aid primary graft dysfunction prediction after heart transplantation; leaves open prospective validation before clinical adoption.
Primary graft dysfunction (PGD), defined as ventricular dysfunction occurring within 24 h following heart transplantation, is a life-threatening complication following heart transplantation. It affects approximately 8–10% of recipients and decreases the 1-year survival from 95% to 75%. The convergence of machine-based learning, multi-omics biomarker discovery, and advanced organ preservation technologies provides a unique opportunity to transform PGD from poorly predictable into a computable, potentially preventable complication. This focused review combines the rapidly evolving evidence at the intersection of artificial intelligence (AI) and PGD biology, offering a novel conceptual framework, which we named the “AI-enhanced PGD prevention pipeline”. This algorithm maps computational tools to every transplant step: donor evaluation, organ preservation and transportation, intraoperative management, and early postoperative surveillance. We critically appraise the evolution from traditional scoring systems (RADIAL, PREDICTA) through contemporary machine learning (ML) models, examine the integration of emerging molecular biomarkers into computational architectures, and evaluate how AI-guided organ preservation platforms may close the loop between prediction and prevention. Moreover, we propose a research agenda to advance this field toward prospective validation and clinical deployment.
No takes yet. Share an insight, caveat, or question.
Wierzbicka et al. (2026) conducted a review in Primary graft dysfunction after heart transplantation. AI-driven prediction models, multi-omics biomarkers, and machine perfusion technologies vs. Traditional clinical risk scores (e.g., RADIAL, PREDICTA) and static cold storage was evaluated on Prediction and prevention of primary graft dysfunction (PGD) within 24 hours after heart transplantation. Machine learning models achieve AUROCs up to 0.868 for predicting primary graft dysfunction after heart transplantation, outperforming traditional risk scores like RADIAL.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: